Journal Article Summary
The article reviews the issues surrounding the diversion and misuse of buprenorphine, a medication used for treating opioid addiction. As outpatient treatment with buprenorphine has grown significantly in the U.S. and other countries, concerns have emerged regarding its potential for misuse and the associated risks. Understanding these behaviors is crucial because they can impact the effectiveness of addiction treatment and public health, highlighting the need for effective strategies to manage and mitigate these issues.
The authors conducted a narrative review, examining existing literature and data on buprenorphine misuse and diversion. They found that behaviors such as sharing or selling prescribed medication are not uncommon, even among individuals without a history of substance use disorders. The review also highlighted that intravenous misuse of buprenorphine occurs globally, with varying prevalence rates depending on the region and healthcare practices. Key findings indicate that while buprenorphine is sometimes misused, its overall safety profile is better than that of full opioid agonists, and the introduction of combination formulations with naloxone has aimed to reduce misuse.
However, the article acknowledges several limitations, including a lack of comprehensive data on the specific sources of diverted buprenorphine and the need for more research on effective prevention strategies. Patients and caregivers should discuss any concerns about buprenorphine treatment with healthcare professionals, particularly regarding the risks of misuse and the importance of adhering to prescribed treatment plans. Open communication can help ensure that treatment remains effective while minimizing the potential for diversion and misuse.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication. Always consult a licensed healthcare professional before using a medical device.
Article Cited
- Lofwall Michelle R., Walsh Sharon L.. A Review of Buprenorphine Diversion and Misuse: The Current Evidence Base and Experiences from Around the World. Journal of addiction medicine 2014. DOI: 10.1097/ADM.0000000000000045. PMID: 25221984. PMCID: PMC4177012.
Featured Pill Pals Product
Pill Pals - Pill Cutter, Crusher, Splitter, and Holder (3 in 1) --- Three in One --- Dukal --- Over The Counter
Pill Pals – Pill Cutter, Crusher, Splitter, and Holder (3 in 1) — Three in One — Dukal — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
